RxDoctor Payments Data

Kevin Stuart, MD

Gastroenterology · Gilroy, CANPI 1912966185

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $4,013 of the $4,915 with a category attached, or 81.6%. Medtronic accounts for 91.0% of it on its own, with 12 other manufacturers making up the rest. 2022 is the largest year on record at $4,563, more than ten times the $253 reported in 2019.

$4,915in general payments, 2019–2025

Across 34 payments — averaging $144.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$4K
  • Braintree Laboratories, Inc.$107
  • Takeda Pharmaceuticals U.S.A., Inc.$78
  • Merck$48
  • Shionogi Inc$39
  • Johnson & Johnson$35
  • plus $139 from 7 others
$246,757in research payments, 2019–2025

Across 17 payments — averaging $14,515 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$216K
  • AstraZeneca$31K

What the payments were for

  • Consulting fees$4,01382%
  • Travel & lodging$1102%
  • Food & beverage$68514%
  • Gifts$1072%

General payments by program year

19
20
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,915 in reported general payments places this provider in the 65th percentile of 1,885 gastroenterology providers in California.

See all gastroenterology providers in California →

Medicare billing

Part B allowed, 2024
$11,663
Medicare patients
41
Services billed
75

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other gastroenterology in Gilroy

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →